These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6817090)

  • 21. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
    van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Is familial hypercholesterolemia under control in the Czech Republic?].
    Freiberger T; Ceska R
    Vnitr Lek; 2007 Jun; 53(6):703-5, 707-8. PubMed ID: 17702130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Twitter to Promote Awareness of Familial Hypercholesterolemia.
    Bangash H; Khan F; He B; Arce M; Kullo IJ
    Circ Genom Precis Med; 2019 Jul; 12(7):e002550. PubMed ID: 31306057
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol].
    Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B
    Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695
    [No Abstract]   [Full Text] [Related]  

  • 25. Living-donor liver transplantation for homozygous familial hypercholesterolemia from a donor with heterozygous hypercholesterolemia.
    Shirahata Y; Ohkohchi N; Kawagishi N; Syouji M; Tsukamoto S; Sekiguchi S; Koyamada N; Oikawa S; Satomi S
    Transpl Int; 2003 Apr; 16(4):276-9. PubMed ID: 12730809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The challenge produced by familial homozygous hypercholesterolemia when treating premature coronary arterial disease in the young.
    Shankarappa RK; Moorthy N; Bhat SP; Dwarakaprasad R; Nanjappa MC
    Cardiol Young; 2009 Jun; 19(3):257-63. PubMed ID: 19344536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects.
    Pocovi M; Civeira F; Alonso R; Mata P
    Semin Vasc Med; 2004 Feb; 4(1):67-74. PubMed ID: 15199435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of coronary heart disease in familial hypercholesterolemia].
    Miserez AR; Keller U
    Ther Umsch; 1994 Oct; 51(10):671-6. PubMed ID: 7839323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The HGAR1 familial hypercholesterolemia pedigree.
    Bailey-Wilson JE; Elston RC
    Genet Epidemiol; 1993; 10(6):529-31. PubMed ID: 8314055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
    Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial defect of apo B-100 in subjects with clinically diagnosed primary hypercholesterolemia: identification of the first family with this disorder in Spain].
    Real JT; Chaves JF; Ascaso JF; Armengod ME; Carmena R
    Med Clin (Barc); 1999 Jun; 113(1):15-7. PubMed ID: 10422071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients' attitudes toward detection of heterozygous familial hypercholesterolemia.
    Andersen LK; Jensen HK; Juul S; Faergeman O
    Arch Intern Med; 1997 Mar; 157(5):553-60. PubMed ID: 9066460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Women at risk of coronary heart disease experience barriers to diagnosis and treatment: a qualitative interview study.
    Frich JC; Malterud K; Fugelli P
    Scand J Prim Health Care; 2006 Mar; 24(1):38-43. PubMed ID: 16464813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The program for detection and treatment of patients with familial hypercholesterolemia (MedPed FH) in the Czech Republic].
    Freiberger T; Soska V; Kuhrová V; Stejskal J
    Cas Lek Cesk; 2000 Apr; 139(7):195-6. PubMed ID: 10916204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Family and polygenic hypercholesteremia: similarities and differencies according to long-term clinical observations].
    Lipovetskiĭ BM
    Ter Arkh; 2009; 81(1):61-4. PubMed ID: 19253714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The treatment of familial hypercholesterolemia and of the dyslipidemias responsible for cardiovascular disease].
    Sampietro T; Licitra R
    G Ital Cardiol; 1999 Feb; 29(2):171-3. PubMed ID: 10088075
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis and treatment of familial hypercholesterolemia in children and adolescents].
    Ose L; Tonstad S; Vesterhus P; Wefring KW
    Tidsskr Nor Laegeforen; 1995 Nov; 115(28):3499-503. PubMed ID: 7491603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portacaval shunt for familial heterozygous hypercholesterolemia.
    Madras PN
    Surg Gynecol Obstet; 1981 Feb; 152(2):187-90. PubMed ID: 7209760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Higher prevalence of familial hypercholesterolemia than expected in adult patients of four family practices in Netherlands].
    Lansberg PJ; Tuzgöl S; van de Ree MA; Defesche JC; Kastelein JJ
    Ned Tijdschr Geneeskd; 2000 Jul; 144(30):1437-40. PubMed ID: 10932696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.